TIM 3 (HAVCR2) Rabbit Polyclonal Antibody
CNY 5,808.00
Cited in 1 publication. |
CNY 300.00
CNY 1,430.00
CNY 3,080.00
Specifications
Product Data | |
Applications | IF, IHC, WB |
Recommend Dilution | WB: 1-2µg/mL. IHC: 2µg/mL. Immunoflorescence start at 20µg/mL. |
Reactivity | Human |
Host | Rabbit |
Clonality | Polyclonal |
Immunogen | TIM3 antibody was raised against a peptide corresponding to 16 amino acids near the amino terminus of human TIM3. The immunogen is located within amino acids 60 - 110 of TIM3. |
Formulation | TIM3 Antibody is supplied in PBS containing 0.02% sodium azide. |
Concentration | 1 mg/ml |
Purification | TIM3 Antibody is affinity chromatography purified via peptide column. |
Conjugation | Unconjugated |
Storage Condition | Store at -20°C as received. |
Predicted Protein Size | Predicted: 33 kDa; Observed: 37 kDa |
Gene Name | hepatitis A virus cellular receptor 2 |
Database Link | |
Background | The immune checkpoint protein TIM3 is a member of the immunoglobulin superfamily and TIM family of proteins that was initially identified as a specific marker of fully differentiated IFN-? producing CD4 T helper 1 (Th1) and CD8 cytotoxic cells. It is a Th1-specific cell surface protein that regulates macrophage activation and negatively regulates Th1-mediated auto- and alloimmune responses, and is also highly expressed on regulatory T cells, monocytes, macrophages, and dendritic cells (1). TIM3 and PD-1 are co-expressed on most CD4 and CD8 T cells infiltrating solid tumors or in hematologic malignancy in mice; blocking TIM3 in conjugation with a PD-1 blockade increases the functionality of exhausted T cells and synergizes with to inhibit tumor growth (2,3). |
Synonyms | FLJ14428; HAVcr-2; KIM-3; Tim-3; TIM3; TIMD-3; TIMD3 |
Note | TIM3 antibody can be used for Western blot at 1 - 2 µg/mL. Antibody can also be used for Immunohistochemistry at 2 µg/mL. For Immunoflorescence start at 20 µg/mL. |
Reference Data |
Citations (1)
The use of this Antibodies has been cited in the following citations: |
---|
Relationship between immune checkpoint proteins, tumour microenvironment characteristics, and prognosis in primary operable colorectal cancer
,null,
The Journal of Pathology: Clinical Research
,PubMed ID 33338327
[HAVCR2]
|
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |